Convulsions and apnoea in a patient infected with New Delhi metallo-β-lactamase-1 Escherichia coli treated with colistin

Journal of Infection

Volumn 63, Issue 6, 2011, Pages 468-470

  Spapen, Herbert D ^a   Honore, Patrick M ^a   Gregoire, Nicolas ^b   Gobin, Patrice ^b   de Regt, Jouke ^a   Martens, Geert A ^a   Pierard, Denis ^a   Couet, William ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b INSERM   (France)

Author keywords

Colistin; NDM lactamase 1; Neurotoxicity

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE 1; C REACTIVE PROTEIN; CIPROFLOXACIN; CLINDAMYCIN; COLISTIMETHATE; COLISTINEB; CREATININE; ETIRACETAM; LACTIC ACID; MEROPENEM; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADD ON THERAPY; ADULT; APNEA; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; CARDIOVASCULAR DISEASE; CASE REPORT; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CONVULSION; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DEBRIDEMENT; DIAPHRAGM PARALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG SENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOTRACHEAL INTUBATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FLUID RESUSCITATION; HUMAN; INDIA; KIDNEY CLEARANCE; LACTATE BLOOD LEVEL; LEG AMPUTATION; LEUKOCYTOSIS; LOADING DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; NEUROTOXICITY; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE INFECTION; RECURRENT DISEASE; SEPSIS; SHOCK; SOFT TISSUE INFECTION;

ANTI-BACTERIAL AGENTS; APNEA; BETA-LACTAMASES; CHROMATOGRAPHY; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; MIDDLE AGED; PLASMA; SEIZURES; THIENAMYCINS;

EID: 82255191797     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.07.008     Document Type: Article

References (10)

1. Gobin P., Lemaître F., Marchand S., Couet W., Olivier J.C. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry. Antimicrob Agents Chemother 2010, 54:1941-1948. 10.1128/AAC.01367-09.
2. Li J., Nation R.L., Turnidge J.D., Milne R.W., Coulthard K., Rayner C.R., et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis 2006, 6:589-601.
3. Falagas M.E., Rafailidis P.I., Ioannidou E., Alexiou V.G., Matthaiou D.K., Karageorgopoulos D.E., et al. Colistin therapy for microbiologically documented multidrug-resistant gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010, 35:194-199. 10.1016/j.ijantimicag.2009.10.005.
4. Falagas M.E., Kasiakou S.K. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006, 10. R27. 10.1186/cc3995.
5. Miller A.D., Ball A.M., Bookstaver P.B., Dornblaser E.K., Bennett C.L. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy 2011, 31:408-423.
6. Iacobone E., Bailly-Salin J., Polito A., Friedman D., Stevens R.D., Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009, 37(10 Suppl):S331-S336.
7. Imberti R., Cusato M., Villani P., Carnevale L., Iotti G.A., Langer M., et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after iv colistin methanesulfonate administration. Chest 2010, 138:1333-1339.
8. Markou N., Markantonis S.L., Dimitrakis E., Panidis D., Boutzouka E., Karatzas S., et al. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study. Clin Ther 2008, 30:143-151.
9. Plachouras D., Karvanen M., Friberg L.E., Papadomichelakis E., Antoniadou A., Tsangaris I., et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 2009, 53:3430-3436. 10.1128/AAC.01361-08.
10. Marchand S., Frat J.P., Petitpas F., Lemaître F., Gobin P., Robert R., et al. Removal of colistin during intermittent haemodialysis in two critically ill patients. J Antimicrob Chemother 2010, 65:1836-1837.